# Switching GLP-1s · PepVault guides

Source: https://pepvault.app/guides/switching-between-glp-1s

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [GLP-1s](https://pepvault.app/guides#glp1)

# Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested

Reviewed November 2026 18 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

No label converts one GLP-1 to another. What the labels say on each switch, Ozempic to Zepbound, shot to pill, CagriSema, and what the switch trials found.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 18
- **Questions:** 7
- **Compounds:** 6

## The short answer

No label gives a conversion from one GLP-1 to another. The only switch rules on a label stay inside semaglutide: one week after the last Wegovy 2.4 mg shot, the Wegovy pill starts at 25 mg. For Ozempic to Zepbound, the Zepbound label starts everyone at 2.5 mg. Trials have tested a few switches; the prescriber sets the rest.

Every number checked at its primary source · Nov 20, 2026 · [18 sources](https://pepvault.app/guides/switching-between-glp-1s#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** Label rules for switches within semaglutide; two open-label switch studies into tirzepatide in type 2 diabetes (12 weeks single-arm, and 40 weeks randomized from dulaglutide); one randomized trial of moving from a shot to orforglipron; no trials yet for CagriSema or retatrutide.

## Is there a conversion chart for switching GLP-1s?

Not from the makers. The Zepbound, Wegovy and Foundayo labels each say their drug is not to be used together with another GLP-1 medicine, and none of them tells a prescriber how to move someone over from a different drug[1](https://pepvault.app/guides/switching-between-glp-1s#source-1) [2](https://pepvault.app/guides/switching-between-glp-1s#source-2) [4](https://pepvault.app/guides/switching-between-glp-1s#source-4). The only conversions printed on a label stay inside one molecule, semaglutide: the Wegovy shot to the Wegovy pill and back[2](https://pepvault.app/guides/switching-between-glp-1s#source-2), and Ozempic 0.5 mg to Rybelsus or Ozempic tablets[3](https://pepvault.app/guides/switching-between-glp-1s#source-3).

The "Ozempic to Zepbound conversion charts" that rank in search are put together by websites, not by Novo Nordisk or Eli Lilly. An expert review published in November 2026 opens with the same point: there are no guidelines for switching from semaglutide to tirzepatide. Its authors propose approximate dose bands for prescribers to use until switching trials confirm exact conversions[11](https://pepvault.app/guides/switching-between-glp-1s#source-11).

<!--promo-->

Switching in PepVault: finish the old protocol and start a new one. Finishing archives it with today's end date, and every dose, weight and side effect you logged stays. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-switching-between-glp-1s-inline&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Switching in PepVault: finish the old protocol and start a new one. Finishing archives it with today's end date, and every dose, weight and side effect you logged stays.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Which GLP-1 switches have been tested, and what do the labels say?

One row per switch people ask about. "Label" is the US prescribing information as of November 2026; "trials" is what has been tested or registered.

| Switch | What the label says | What trials tested | Our deeper guide |
| --- | --- | --- | --- |
| Ozempic or Wegovy to Zepbound or Mounjaro (semaglutide to tirzepatide) | No switch rule. Zepbound starts at 2.5 mg weekly for 4 weeks, then steps up by 2.5 mg[1](https://pepvault.app/guides/switching-between-glp-1s#source-1) | SURPASS-SWITCH-2: type 2 diabetes, from any of three GLP-1s (55% on semaglutide), straight to 5 mg for 12 weeks[5](https://pepvault.app/guides/switching-between-glp-1s#source-5). No reported trial in people without diabetes | Semaglutide vs tirzepatide side effects; Ozempic, Wegovy, Mounjaro and Zepbound |
| Zepbound to Wegovy or Ozempic (tirzepatide to semaglutide) | No switch rule. The Wegovy shot starts at 0.25 mg weekly for 4 weeks[2](https://pepvault.app/guides/switching-between-glp-1s#source-2) | None found in the registry or PubMed | Ozempic, Wegovy, Mounjaro and Zepbound |
| Wegovy shot to Wegovy pill | One week after the last 2.4 mg shot, start 25 mg tablets once daily[2](https://pepvault.app/guides/switching-between-glp-1s#source-2) | The label's own rule | The Wegovy pill |
| Wegovy pill to Wegovy shot | The day after the last 25 mg tablet, start 2.4 mg weekly; 1.7 mg if 25 mg tablets were not tolerated[2](https://pepvault.app/guides/switching-between-glp-1s#source-2) | The label's own rule | The Wegovy pill |
| Ozempic shot to Rybelsus or Ozempic tablets | From Ozempic 0.5 mg only: one week later, Rybelsus 7 or 14 mg, or Ozempic tablets 4 or 9 mg[3](https://pepvault.app/guides/switching-between-glp-1s#source-3) | The label's own rule | The Wegovy pill |
| Zepbound or Wegovy to Foundayo (orforglipron) | No switch rule. Foundayo starts at 0.8 mg daily for at least 30 days[4](https://pepvault.app/guides/switching-between-glp-1s#source-4) | ATTAIN-MAINTAIN: straight to the 9 mg tablet dose within 14 days of the last shot[7](https://pepvault.app/guides/switching-between-glp-1s#source-7) | Foundayo vs the shots; Keeping weight off after a GLP-1 |
| Ozempic or Wegovy to CagriSema | Not FDA approved | A phase 3 switch trial is recruiting: type 2 diabetes, three switch regimens[8](https://pepvault.app/guides/switching-between-glp-1s#source-8) | CagriSema vs Zepbound vs Wegovy |
| Zepbound to retatrutide | Not FDA approved | None. TRIUMPH-1, the main phase 3 obesity trial, excluded anyone who took a weight-loss drug in the 90 days before screening[9](https://pepvault.app/guides/switching-between-glp-1s#source-9) | Switching from tirzepatide to retatrutide |
| A GLP-1 shot to aleniglipron (a pill in trials) | Not FDA approved | Structure Therapeutics' SWITCH study: from an approved GLP-1 shot, several starting doses, 12 weeks; results expected Q4 2026, per the company[17](https://pepvault.app/guides/switching-between-glp-1s#source-17) | Aleniglipron and its switch trial |
| Compounded semaglutide or tirzepatide to a brand | No switch rule; FDA does not review compounded drugs for safety, effectiveness or quality[10](https://pepvault.app/guides/switching-between-glp-1s#source-10) | None. The CagriSema switch trial excludes people on compounded semaglutide[8](https://pepvault.app/guides/switching-between-glp-1s#source-8) | Is compounded semaglutide the same as Ozempic? |

## What happened when people switched from semaglutide to tirzepatide?

The one prospective test of moving straight onto tirzepatide is SURPASS-SWITCH-2, a Lilly-run study of 152 adults with type 2 diabetes on a stable dose of liraglutide, semaglutide or dulaglutide for at least three months: 55% were on semaglutide (most often 1.0 mg) and 42% on dulaglutide. Everyone moved straight to tirzepatide 5 mg, skipping the 2.5 mg starting step, and stayed there for 12 weeks[5](https://pepvault.app/guides/switching-between-glp-1s#source-5).

Over those 12 weeks HbA1c (the three-month blood sugar average) fell by a further 0.43 points and weight by a further 2.15 kg, on top of what the earlier drug had done. Stomach side effects showed up in 20 people (13.2%), and 3 (2%) stopped tirzepatide because of side effects[5](https://pepvault.app/guides/switching-between-glp-1s#source-5). The study had no comparison group. Our reading: 5 mg is the lowest maintenance dose on the Zepbound label, so these numbers describe the first 12 weeks, not where tirzepatide tops out[1](https://pepvault.app/guides/switching-between-glp-1s#source-1).

The longer trial switched from dulaglutide, not semaglutide. In SURPASS-SWITCH, 282 adults on low-dose dulaglutide either moved to tirzepatide, starting at 2.5 mg and stepping up to 15 mg or the highest dose they tolerated, or stepped dulaglutide up. At 40 weeks weight was down 10.5 kg on tirzepatide against 3.6 kg on more dulaglutide[6](https://pepvault.app/guides/switching-between-glp-1s#source-6). Beyond these, there is a chart review of 15 people with type 2 diabetes in Japan who moved from semaglutide 1.0 mg to tirzepatide starting at 2.5 mg[12](https://pepvault.app/guides/switching-between-glp-1s#source-12), and a Canadian registry study of about 650 people (switchers with and without diabetes, plus a group that stayed on semaglutide), with primary completion estimated for December 2026 on ClinicalTrials.gov[13](https://pepvault.app/guides/switching-between-glp-1s#source-13). No trial has yet tested this switch in people without diabetes.

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Half-life](https://pepvault.app/glossary/half-life)
- [Maintenance dose](https://pepvault.app/glossary/maintenance-dose)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Compounded drug](https://pepvault.app/glossary/compounded)
- [Placebo](https://pepvault.app/glossary/placebo)
- [HbA1c (A1C)](https://pepvault.app/glossary/hba1c)

## What happened when people moved from a GLP-1 shot to Foundayo?

ATTAIN-MAINTAIN took 376 people who had just finished 72 weeks of Zepbound or Wegovy in SURMOUNT-5 and gave them orforglipron (Foundayo) or a placebo pill. The first pill came, ideally, within 14 days of the last shot, and it started at the dose equal to the 9 mg tablet, not the 0.8 mg the label sets for new users. It then stepped up every 4 weeks to the 17.2 mg tablet dose or the highest dose each person tolerated[7](https://pepvault.app/guides/switching-between-glp-1s#source-7).

The jump went smoothly: in the first 4 weeks, 10.5% of those coming off Zepbound and 9.5% of those coming off Wegovy had nausea, vomiting or diarrhea, mostly mild to moderate, and nobody needed a lower dose[7](https://pepvault.app/guides/switching-between-glp-1s#source-7). Among people whose weight had levelled off on the shot, the pill kept 74.7% (from Zepbound) and 79.3% (from Wegovy) of the loss after a year, against 49.2% and 37.6% on placebo; Keeping weight off after a GLP-1 takes that result further. The trial had no group that stayed on the shot[7](https://pepvault.app/guides/switching-between-glp-1s#source-7).

The 9 mg start is the trial's, not the label's. As of its August 2026 version, the Foundayo label still starts at 0.8 mg and gives no rule for coming off a shot[4](https://pepvault.app/guides/switching-between-glp-1s#source-4).

## How long does the old GLP-1 stay in your body after a switch?

Weeks, which is why the gap between drugs matters. A half-life is the time it takes for half of a drug to leave the body. Semaglutide's is about one week, and the Wegovy label says it stays in the blood for about 5 to 7 weeks after the last 2.4 mg shot or 25 mg tablet[2](https://pepvault.app/guides/switching-between-glp-1s#source-2). Tirzepatide's is about 5 days[1](https://pepvault.app/guides/switching-between-glp-1s#source-1). The chart shows how a weekly semaglutide dose fades after the last shot.

Try it

How Semaglutide builds up

An estimate from a half-life of about 6.9 days, one dose a week for four weeks. The shape of the level, not a measurement.

[Try your own schedule](https://pepvault.app/tools/peptide-half-life-calculator) [Semaglutide in the library](https://pepvault.app/peptides/semaglutide)

The labels' own gaps are short: one week from the Wegovy shot to the pill, and the next day from the pill to the shot[2](https://pepvault.app/guides/switching-between-glp-1s#source-2). So the first dose of the new form lands while semaglutide from the old one is still in the blood.

## Which GLP-1 switch trials are coming?

These switch trials are registered and not yet reported, as of November 20, 2026; every date is the registry's estimate.

| Trial | Switch | People | Primary completion (ClinicalTrials.gov) |
| --- | --- | --- | --- |
| NCT07817251 (Novo Nordisk, phase 3) | Semaglutide 1.0 or 2.0 mg to CagriSema, three regimens; side effects to week 16[8](https://pepvault.app/guides/switching-between-glp-1s#source-8) | 210, type 2 diabetes | June 9, 2027 |
| MARITIME-SWITCH, NCT07575399 (Amgen, phase 3) | A weekly GLP-1 to MariTide, two schedules; weight at week 68[14](https://pepvault.app/guides/switching-between-glp-1s#source-14) | 300 without diabetes, at least 10% lost on the weekly drug | January 3, 2028 |
| VESPER-SWITCH, NCT07845500 (Pfizer, phase 3) | Weekly semaglutide or tirzepatide to monthly berobenatide, against staying on; weight at week 32[15](https://pepvault.app/guides/switching-between-glp-1s#source-15) | 660 without diabetes | February 16, 2028 |
| SYNCHRONIZE-START, NCT07855900 (Boehringer Ingelheim, phase 3b) | Semaglutide or tirzepatide to survodutide, beside people starting fresh; weight at week 52[18](https://pepvault.app/guides/switching-between-glp-1s#source-18) | 350 without diabetes | November 6, 2029 |
| NCT07868354 (Novo Nordisk, phase 1) | Tirzepatide maintenance dose to zenagamtide; side effects to day 57[16](https://pepvault.app/guides/switching-between-glp-1s#source-16) | 60, with or without type 2 diabetes | September 7, 2028 |

In the CagriSema trial, people on Ozempic or Wegovy move to CagriSema at one of three doses; two arms then step down to a lower dose, and the record counts side effects over 16 weeks[8](https://pepvault.app/guides/switching-between-glp-1s#source-8).

## What should you settle with your prescriber before switching GLP-1s?

1. Write down your current drug, dose, and the date and time of your last dose. Every timing question starts from that date.
2. Ask which day the first dose of the new drug falls on. Where a label sets it, it is one week after the last Wegovy shot for the pill, and the next day from the pill to the shot[2](https://pepvault.app/guides/switching-between-glp-1s#source-2).
3. Ask what the starting dose is and why. Zepbound's label starts at 2.5 mg and Foundayo's at 0.8 mg[1](https://pepvault.app/guides/switching-between-glp-1s#source-1) [4](https://pepvault.app/guides/switching-between-glp-1s#source-4); a higher start, as in SURPASS-SWITCH-2 or ATTAIN-MAINTAIN, is the trial's, and your prescriber decides if it applies[5](https://pepvault.app/guides/switching-between-glp-1s#source-5) [7](https://pepvault.app/guides/switching-between-glp-1s#source-7).
4. Ask how the steps up go: at least 4 weeks per step on Zepbound, at least 30 days on Foundayo[1](https://pepvault.app/guides/switching-between-glp-1s#source-1) [4](https://pepvault.app/guides/switching-between-glp-1s#source-4).
5. Ask about the overlap. The labels advise against taking two GLP-1 medicines together, so the old drug stops before the new one starts[1](https://pepvault.app/guides/switching-between-glp-1s#source-1) [2](https://pepvault.app/guides/switching-between-glp-1s#source-2) [4](https://pepvault.app/guides/switching-between-glp-1s#source-4).
6. If you take the pill for birth control, ask about backup. The Zepbound label advises a non-oral or barrier method for 4 weeks after starting and after each step up, and Foundayo's for 30 days[1](https://pepvault.app/guides/switching-between-glp-1s#source-1) [4](https://pepvault.app/guides/switching-between-glp-1s#source-4).
7. Log your weight and any side effects from the first new dose, so the next visit runs on your own numbers.

**Commonly reported:** in the switch trials, nausea, constipation, diarrhea or vomiting in the first weeks on the new drug, mostly mild to moderate[5](https://pepvault.app/guides/switching-between-glp-1s#source-5) [7](https://pepvault.app/guides/switching-between-glp-1s#source-7).

<!--promo-->

PepVault keeps your weigh-ins on one chart across both protocols, so the weeks before and after the switch sit side by side. [Track your weight in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-switching-between-glp-1s-inline&mt=8)

<!--/promo-->

**When to get help** Severe stomach pain that does not ease, sometimes reaching the back, is a reason to stop the drug and contact your prescriber promptly, as the labels advise[1](https://pepvault.app/guides/switching-between-glp-1s#source-1) [4](https://pepvault.app/guides/switching-between-glp-1s#source-4).

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. ZEPBOUND (tirzepatide) injection, prescribing information. Eli Lilly and Company. DailyMed, SPL version 40, revised 08/2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)
2. WEGOVY (semaglutide) injection and tablets, prescribing information. Novo Nordisk. DailyMed, SPL version 19, revised 06/2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
3. RYBELSUS and OZEMPIC (semaglutide) tablets, prescribing information. Novo Nordisk. DailyMed, SPL version 14, revised 01/2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27f15fac-7d98-4114-a2ec-92494a91da98)
4. FOUNDAYO (orforglipron) tablets, prescribing information. Eli Lilly and Company. DailyMed, SPL version 10, 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62)
5. Jabbour S et al. Switching to tirzepatide 5 mg from glucagon-like peptide-1 receptor agonists: clinical expectations in the first 12 weeks of treatment (SURPASS-SWITCH-2). Endocr Pract. 2024. [PubMed 38723893](https://pubmed.ncbi.nlm.nih.gov/38723893/)
6. Billings LK et al. Comparison of dose escalation versus switching to tirzepatide among people with type 2 diabetes inadequately controlled on lower doses of dulaglutide (SURPASS-SWITCH). Ann Intern Med. 2025. [PubMed 40183678](https://pubmed.ncbi.nlm.nih.gov/40183678/)
7. Aronne LJ et al. Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial. Nat Med. 2026. [PubMed 42120723](https://pubmed.ncbi.nlm.nih.gov/42120723/)
8. Safety and tolerability of 3 switch regimens from semaglutide 1.0 mg and 2.0 mg to CagriSema in participants with type 2 diabetes. Novo Nordisk. ClinicalTrials.gov NCT07817251. [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07817251)
9. TRIUMPH-1: retatrutide in participants who have obesity or overweight. Eli Lilly and Company. ClinicalTrials.gov NCT05929066 (eligibility criteria). [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05929066)
10. FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration. Content current as of October 1, 2026. [fda.gov](https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss)
11. Schwartzberg E et al. Switching between semaglutide and tirzepatide in obesity management: an expert-consensus framework for approximate clinical efficacy-matched switching doses. Expert Opin Pharmacother. 2026. [PubMed 42952336](https://pubmed.ncbi.nlm.nih.gov/42952336/)
12. Kurinami N et al. Early dose escalation of tirzepatide after switching from semaglutide in type 2 diabetes mellitus. Endocrinol Metab (Seoul). 2025. [PubMed 41088952](https://pubmed.ncbi.nlm.nih.gov/41088952/)
13. Metabolic effects of switching from injectable semaglutide to tirzepatide: a retrospective study of the LMC Diabetes Registry. ClinicalTrials.gov NCT07889453. [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07889453)
14. Switching from GLP-1 receptor agonists to maridebart cafraglutide in adults with obesity or overweight. Amgen. ClinicalTrials.gov NCT07575399. [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07575399)
15. VESPER-SWITCH: the switch to monthly berobenatide for maintaining weight in adults on weekly semaglutide or tirzepatide. Pfizer. ClinicalTrials.gov NCT07845500. [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07845500)
16. Tolerability when switching from tirzepatide to zenagamtide in participants with overweight or obesity. Novo Nordisk. ClinicalTrials.gov NCT07868354. [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07868354)
17. Structure Therapeutics. Third quarter 2026 financial results and recent highlights (Form 8-K, Exhibit 99.1). November 9, 2026. [sec.gov](https://www.sec.gov/Archives/edgar/data/1888886/000110465926124494/tm2629207d1_ex99-1.htm)
18. SYNCHRONIZE-START: initiation strategies for survodutide, including switching from semaglutide or tirzepatide, in people with overweight or obesity without diabetes. Boehringer Ingelheim. ClinicalTrials.gov NCT07855900. [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07855900)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · GLP-1

Guide · GLP-1

### [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)

Ozempic, Wegovy, Mounjaro and Zepbound side by side: ingredient, approved use, dose steps, top dose, missed-dose rule and trial weight loss, from each FDA label

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [Semaglutide Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/semaglutide)
- [Tirzepatide Studied range: 2.5–15 mg](https://pepvault.app/peptides/tirzepatide)
- [Orforglipron Studied range: 0.8–17.2 mg](https://pepvault.app/peptides/orforglipron)
- [Semaglutide (oral) Studied range: 1.5–25 mg](https://pepvault.app/peptides/semaglutide-oral)
- [CagriSema Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/cagrisema)
- [Retatrutide Studied range: 1–12 mg](https://pepvault.app/peptides/retatrutide)

## Related guides

- Guide · GLP-1s

  ### [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)

  No trial has tested a switch from tirzepatide to retatrutide. What each drug's trials and the Zepbound label say, how the two differ, and what is still unknown.

  Read the guide
- Guide · GLP-1s

  ### [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)

  Foundayo (orforglipron) is a daily GLP-1 pill, not a peptide. Its ATTAIN and ACHIEVE results beside Zepbound's SURMOUNT and Wegovy's STEP, in one table.

  Read the guide
- Guide · GLP-1s

  ### [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)

  The Wegovy pill is daily semaglutide, FDA approved in December 2025. How to take it, its doses beside the weekly shot's, and OASIS 4 next to STEP 1.

  Read the guide
- Guide · GLP-1s

  ### [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)

  Compounded semaglutide and tirzepatide are not FDA-approved. What compounding is, what the FDA decided and when, and how a vial differs from a brand pen.

  Read the guide
- Guide · GLP-1s

  ### [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)

  Aleniglipron is Structure Therapeutics' daily GLP-1 pill in testing: its phase 2 numbers, every trial, and what its shot-to-pill SWITCH trial must beat.

  Read the guide
- Guide · GLP-1s

  ### [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)

  What each trial tested for keeping weight off after a GLP-1: staying on, a lower dose, switching to a pill and exercise, with every result in one by-drug table.

  Read the guide
- Guide · GLP-1s

  ### [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)

  Semaglutide vs tirzepatide side effects in the same trials: nausea, vomiting, reflux, hair loss and injection-site rates side by side, and how many stopped.

  Read the guide
- Guide · GLP-1s

  ### [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)

  Ozempic, Wegovy, Mounjaro and Zepbound side by side: ingredient, approved use, dose steps, top dose, missed-dose rule and trial weight loss, from each FDA label

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Half-life](https://pepvault.app/glossary/half-life)
- [Maintenance dose](https://pepvault.app/glossary/maintenance-dose)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Compounded drug](https://pepvault.app/glossary/compounded)
- [Placebo](https://pepvault.app/glossary/placebo)
- [HbA1c (A1C)](https://pepvault.app/glossary/hba1c)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
